This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Malignant Man is a 2011 graphic novel by James Wan.
| Malignant Man | |
|---|---|
| Publication information | |
| Publisher | Boom! Studios |
| Format | Limited series |
| Publication date | April – August 2011 |
| No. of issues | 4 |
| Creative team | |
| Created by | James Wan |
| Written by | James Wan (story) Michael Alan Nelson (writer) |
| Artist(s) | Piotr Kowalski |
| Letterer(s) | Steve Wands |
| Colorist(s) | Jordie Bellaire |
| Editor(s) | Matt Gagnon |
| Collected editions | |
| Softcover | ISBN 978-1608860708 |
Synopsis
editDiagnosed with terminal cancer, Alan Gates is resigned to die, until he learns that his tumor is really a parasite. With a new lease on life and incredible, otherworldly powers, Alan must fight against an evil army buried beneath society's skin, all the while unlocking the secrets of his forgotten past.[1]
Film adaptation
editIn June 2014, 20th Century Fox acquired the rights to the comic and set James Wan to direct and produce the adaptation.[2] In 2016, Brad Peyton signed on to direct the film with Wan still producing the film through his Atomic Monster banner.[3] One year later, Rebecca Thomas replaced Peyton as director.[4]
Wan would later clarify that his film Malignant was not based on the graphic novel despite the name similarities.[5]
References
edit- ^ Amazon
- ^ Fox Acquires ‘Malignant Man’; ‘Fast 7’s James Wan Eyeing To Direct
- ^ 'San Andreas' Director Teams With James Wan for 'Malignant Man' (Exclusive)
- ^ McNary, Dave (August 7, 2017). "'Stranger Things' Director Rebecca Thomas to Helm Fox Sci-Fi Thriller 'Malignant'". Variety. Retrieved October 9, 2023.
- ^ Wan, James. "Umm, just a little clarification". Facebook. Retrieved January 24, 2020.
 | This article about a graphic novel of the 2010s is a stub. You can help Wikipedia by expanding it. See guidelines for writing about novels. Further suggestions might be found on the article's talk page. |